Skip to main content

Day: January 23, 2025

Disc Medicine Announces Pricing of $225.5 Million Upsized Public Offering of Common Stock and Pre-Funded Warrants

WATERTOWN, Mass., Jan. 22, 2025 (GLOBE NEWSWIRE) — Disc Medicine, Inc. (NASDAQ: IRON) (Disc), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases, today announced the pricing of its upsized underwritten offering of shares of its common stock and, in lieu of common stock to certain investors that so choose, pre-funded warrants to purchase shares of its common stock. Disc is selling 3,918,182 shares of common stock and pre-funded warrants to purchase 181,818 shares of common stock in the offering. The shares of common stock are being sold at an offering price of $55.00 per share, and the pre-funded warrants are being sold at an offering price of $54.9999 per pre-funded warrant, which represents the per...

Continue reading

Andes Technology D45-SE Processor Achieves ISO 26262 ASIL-D Certification for Functional Safety

HSINCHU, TAIWAN, Jan. 23, 2025 (GLOBE NEWSWIRE) — Andes Technology, a leading provider of RISC-V processor cores, today announced that its D45-SE processor has successfully achieved ISO 26262 ASIL-D with the certification of SGS TÜV.  This certification marks a significant achievement for Andes Technology, confirming that the D45-SE processor meets the highest automotive safety standards required for safety-critical applications in the automotive industry. The D45-SE processor is now qualified for use in the most mission-critical automotive systems. Key Highlights:ASIL-D Certification: The D45-SE processor is fully compliant with ISO 26262 series of standards including Parts 2, 4, 5, 7, 8 and 9, and has achieved ASIL-D certification. Certified by SGS TÜV: The certification was granted following a rigorous evaluation process by...

Continue reading

Xeriant, Inc. Provides Update on Litigation Against XTI Aircraft Co.

BOCA RATON, Fla., Jan. 22, 2025 (GLOBE NEWSWIRE) — Xeriant, Inc. (OTCQB: XERI), an aerospace technology company dedicated to the development and commercialization of advanced materials, announces an update regarding ongoing litigation against XTI Aircraft Co. (“XTI”), the wholly owned and principal operating subsidiary of XTI Aerospace Inc. (Nasdaq: XTIA). On February 29, 2024, Xeriant, Inc, filed an Amended Complaint in the United States District Court for the Southern District of New York against XTI alleging that XTI, engaged over a period of time in (1) intentional fraudulent conduct against Xeriant, (2) fraudulent concealment, (3) breach of contract, (4) quantum meruit, (5) unjust enrichment, (6) unfair competition, and (7) misappropriation of confidential information, and sought, among other things, damages in excess of $500...

Continue reading

Crown Castle Announces Tax Reporting Information for 2024 Distributions

HOUSTON, Jan. 22, 2025 (GLOBE NEWSWIRE) — Crown Castle Inc. (NYSE: CCI) (“Crown Castle”) announced today certain year-end tax reporting information for its 2024 distributions. The following table summarizes, for income tax purposes, the nature of distributions paid to holders of Crown Castle Common Stock, par value $.01 per share (“Common Stock”), presented on a per share basis, during the calendar year ended December 31, 2024. Stockholders are urged to consult with their personal tax advisors as to their specific tax treatment of Crown Castle’s distributions. Crown Castle Common StockTicker Symbol: CCICUSIP 22822V101Record Date Payable Date Cash Distribution (per share) Ordinary TaxableDividend(per share) Qualified Taxable Dividend(per share)* Section 199A Dividend(per share)* Non-Taxable Distribution (per share)3/15/2024 3/28/2024 $1.565000 $0.884582 $0.018596 $0.865986 $0.6804186/14/2024 6/28/2024 $1.565000 $0.884582 $0.018596 $0.865986 $0.6804189/13/2024 9/30/2024 $1.565000 $0.884582 $0.018596 $0.865986 $0.68041812/13/2024 12/31/2024 $1.565000 $0.884582 $0.018596 $0.865986 $0.680418*Qualified...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.